Nathan D. Lakey MBA, Founding Principal, President & Chief Executive Officer and Director, Orion Genomics, LLC (St. Louis MO); Chairman and Co-Founder of Orion Biosains (Kuala Lumpur, Malaysia and Jakarta, Indonesia).
Mr. Lakey received a BA in Biochemistry from the University of Texas at Austin and an MBA with Honors from Washington University St. Louis where he received the C. William Emory Executive MBA Award. Mr. Lakey has more than 27 years of experience in genomics, holds 8 issued US patents and numerous issued and pending patents globally. He was Director of DNA Sequencing at Millennium Pharmaceuticals, Inc., and helped form three of Millennium’s business units, Millennium Predictive Medicine, Millennium Biotherapeutics and Cereon Inc. Before joining Millennium, Mr. Lakey held various positions with Molecular Dynamics, Ambion Inc., and Harvard Medical School’s Department of Genetics in the laboratory of next generation sequencing pioneer, George M. Church.
Mr. Lakey was regionally recognized with the top 40 under 40 Award (2004), presented with the Missouri governor's Top Technology Award (2005), named as a top entrepreneur in St. Louis (1900-2000) by St. Louis Commerce Magazine (2007). Orion Genomics was listed as a top 50 Company in the St. Louis region on numerous occasions, named as a Red Herring top 200 Company nationally in (2006), featured as 1 of the 8 most disruptive companies globally by the BBC (2016), and highlighted recently in Nature News for having a positive environmental impact in Southeast Asia (2017). Mr. Lakey currently serves as Chairman of the Investment Advisory Committee, Biogenerator, Co-Founder and Chairman of Orion Biosains Sdn Bhd (Malaysia) and PT Orion Biosains (Indonesia), and serves on the boards of Orion Genomics LLC, Missouri Baptist Hospital, Apse LLC, and YourBevCo LLC.
Mr. Nathan D. Lakey, President / CEO
The Role of Molecular Precision Agriculture in Oil Palm Sustainability and its Economic Impact in Southeast Asia
Day 2 [Tue 01, August], at 02:00 PM